Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com began coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a report issued on Tuesday. The firm set a “hold” rating on the stock.

Aspira Women’s Health Price Performance

Shares of NASDAQ:AWH opened at $0.09 on Tuesday. The business’s fifty day moving average price is $0.24 and its two-hundred day moving average price is $0.59. Aspira Women’s Health has a fifty-two week low of $0.08 and a fifty-two week high of $3.63. The stock has a market capitalization of $1.66 million, a price-to-earnings ratio of -0.08 and a beta of 1.57.

Aspira Women’s Health (NASDAQ:AWH) last posted its earnings results on Thursday, March 27th. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.21) by $0.13. The firm had revenue of $2.35 million during the quarter, compared to the consensus estimate of $3.00 million.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Aspira Women’s Health stock. Pine Valley Investments Ltd Liability Co acquired a new stake in Aspira Women’s Health Inc. (NASDAQ:AWH) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 31,200 shares of the company’s stock, valued at approximately $25,000. Pine Valley Investments Ltd Liability Co owned about 0.19% of Aspira Women’s Health as of its most recent filing with the SEC. Institutional investors and hedge funds own 12.19% of the company’s stock.

Aspira Women’s Health Company Profile

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.